Nirsevimab

Nirsevimab
Monoclonal antibody
Type Whole antibody
Source Human
Target respiratory syncytial virus fusion protein
Clinical data
Synonyms MEDI8897
ATC code
  • none
Identifiers
CAS Number
UNII
Chemical and physical data
Formula C6494H10060N1708O2050S46
Molar mass 146.3 g/mol

Nirsevimab (MEDI8897) (INN) is a monoclonal antibody designed for the treatment of respiratory syncytial virus.[1][2]

This drug is being developed by MedImmune, LLC.

References

  1. ↑ Statement On A Nonproprietary Name Adopted By The USAN Council - Nirsevimab, American Medical Association.
  2. ↑ World Health Organization (2018). "International Nonproprietary Names for Pharmaceutical Substances (INN). Proposed INN: List 119" (PDF). WHO Drug Information. 32 (2).
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.